Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia

Key Points

Key points are not available for this paper at this time.

Abstract

A new prognostic score including ASXL1 status, age, hemoglobin, WBC, and platelet counts defines three groups of CMML patients with distinct outcomes. Based on concordance analysis, this score appears more discriminative than those based solely on clinical parameters.

Bookmark

Cite This Study

Itzykson et al. (Tue,) studied this question.

synapsesocial.com/papers/69dcc71c89c4deb67d359c63 https://doi.org/https://doi.org/10.1200/jco.2012.47.3314

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of <i>c-Cbl</i> , in Myeloid Malignancies2008 · 293 citations
2Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms2010 · 243 citations
3C‐terminal nucleophosmin mutations are uncommon in chronic myeloid disorders2006 · 47 citations
4Frequent pathway mutations of splicing machinery in myelodysplasia2011 · 2,056 citations
5Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes2012 · 231 citations

Bookmark